rizatriptan (Q212171)

From Wikidata

Jump to navigation Jump to search

chemical compound

MK-0462
MK-462
MK-A462
N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine
risatriptan
N,N-dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine
MK 462 free base

Language	Label	Description	Also known as
English	rizatriptan	chemical compound	MK-0462 MK-462 MK-A462 N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine risatriptan N,N-dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine MK 462 free base

Statements

type of chemical entity

0 references

chemical compound

0 references

0 references

chemical structure

Rizatriptan.svg
1,527 × 932; 8 KB

0 references

image of molecular model or crystal lattice model

Rizatriptan 3D ball-and-stick.png
2,000 × 1,816; 540 KB

ball-and-stick model

0 references

269.164046 dalton

1 reference

language of work or name

rizatriptan (English)

3 October 2016

chemical formula

C₁₅H₁₉N₅

1 reference

language of work or name

rizatriptan (English)

19 November 2016

canonical SMILES

CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3

1 reference

language of work or name

rizatriptan (English)

19 November 2016

defined daily dose

10 milligram

route of administration

oral administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=N02CC04

active ingredient in

1 reference

14 February 2018

World Health Organisation international non-proprietary name

rizatriptan (English)

1 reference

language of work or name

rizatriptan (English)

3 October 2016

medical condition treated

1 reference

Drug Indications Extracted from FAERS

2 October 2018

significant drug interaction

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

tranylcypromine

1 reference

High-priority drug–drug interactions for use in electronic health records

vasoconstriction

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

mental status change

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

mental status change

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

mental status change

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

5-hydroxytryptamine receptor 1A

subject has role

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

language of work or name

17 August 2016

5-hydroxytryptamine receptor 1B

subject has role

2 references

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

language of work or name

17 August 2016

Open Targets Platform

14 August 2023

https://platform.opentargets.org/drug/CHEMBL905

5-hydroxytryptamine receptor 1D

subject has role

2 references

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

language of work or name

17 August 2016

Open Targets Platform

14 August 2023

https://platform.opentargets.org/drug/CHEMBL905

5-hydroxytryptamine receptor 1E

subject has role

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

language of work or name

17 August 2016

5-hydroxytryptamine receptor 1F

subject has role

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

language of work or name

17 August 2016

subject has role

serotonin receptor agonists

2 references

5 March 2018

Medical Subject Headings

MeSH descriptor ID

15 March 2018

Commons category

Rizatriptan

0 references

Identifiers

InChI=1S/C15H19N5/c1-19(2)6-5-13-8-17-15-4-3-12(7-14(13)15)9-20-11-16-10-18-20/h3-4,7-8,10-11,17H,5-6,9H2,1-2H3

1 reference

language of work or name

rizatriptan (English)

19 November 2016

ULFRLSNUDGIQQP-UHFFFAOYSA-N

2 references

language of work or name

rizatriptan (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

2 references

Global Substance Registration System

language of work or name

rizatriptan (English)

19 November 2016

ULFRLSNUDGIQQP-UHFFFAOYSA-N

CAS Common Chemistry

10 April 2021

https://commonchemistry.cas.org/detail?cas_rn=144034-80-0

1 reference

language of work or name

Rizatriptan (English)

19 November 2016

1 reference

language of work or name

rizatriptan (English)

19 November 2016

Reaxys registry number

7078976

1 reference

language of work or name

rizatriptan (English)

3 October 2016

mapping relation type

1 reference

language of work or name

RIZATRIPTAN (English)

19 November 2016

1 reference

language of work or name

RIZATRIPTAN (English)

19 November 2016

UniChem compound ID

1 reference

DSSTox substance ID

1 reference

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

812-626-9

0 references

ECHA Substance Infocard ID

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

27 December 2018

Dimethyl-[2-(5-[1,2,4]triazol-1-ylmethyl-1H-indol-3-yl)-ethyl]-amine (English)

CAS no.: 144034-80-0 (English)

1 reference

language of work or name

Rizatriptan (English)

publication date

17 November 2015

Guide to Pharmacology Ligand ID

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

language of work or name

rizatriptan (English)

19 November 2016

MeSH descriptor ID

1 reference

Medical Subject Headings

MeSH descriptor ID

14 March 2018

1 reference

Global Substance Registration System

language of work or name

rizatriptan (English)

19 November 2016

1 reference

language of work or name

Rizatriptan (English)

19 November 2016

Human Metabolome Database ID

1 reference

based on heuristic

inferred from InChIKey

1 reference

Global Substance Registration System

language of work or name

rizatriptan (English)

19 November 2016

MedlinePlus drug identifier

0 references

PatientsLikeMe treatment ID

0 references

1 reference

Global Substance Registration System

language of work or name

rizatriptan (English)

19 November 2016

Probes And Drugs ID

0 references

1 reference

1 reference

language of work or name

Rizatriptan (English)

19 January 2016

1 reference

Freebase Data Dumps

publication date

28 October 2013

Microsoft Academic ID

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

1 reference

Global Substance Registration System

language of work or name

rizatriptan (English)

19 November 2016

WikiProjectMed ID

0 references

Sitelinks

Wikipedia(18 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(1 entry)

commonswiki Category:Rizatriptan

Retrieved from "https://www.wikidata.org/w/index.php?title=Q212171&oldid=2135637940"